Statement Of Cash Flows [Abstract]

Innate Pharma - Filing #2821023

Concept 2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income
962,000 EUR
1 290 EUR
Cash flows from (used in) operations before changes in working capital
2 562 EUR
5 321 EUR
Increase (decrease) in working capital
49 206 EUR
40 246 EUR
Adjustments for decrease (increase) in trade and other receivables
22 919 EUR
110 296 EUR
Adjustments for increase (decrease) in trade and other payables
6 528 EUR
1 385 EUR
Adjustments for increase (decrease) in employee benefit liabilities
216,000 EUR
685,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
3 000 EUR
EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.